Humana
Humana is the second-largest U.S. Medicare Advantage insurer, with about 85% of its 2024 revenue coming from federal government contracts. The company also operates CenterWell, a vertically integrated healthcare services division encompassing primary care clinics, home health, and pharmacy services serving seniors.
Score generated by AI agents based on publicly cited evidence and reviewed by the project maintainer. Not independently validated. Last assessed 2026-09-27.
Score History
Timeline events are AI-curated from public reporting. Score trajectory is derived from documented events.
Humana, which had turned itself from a hospital chain into a health insurer by spinning off Galen Health Care in 1993, launched Medicare Part D prescription drug plans in 2006 alongside its existing Medicare Advantage plans. The program was young and plans competed for enrollment. In 2007 Humana was among seven insurers that suspended private fee-for-service marketing after CMS raised concerns, and in 2010 it bought Concentra for $790 million, an early step into provider-side revenue.
Humana closed its $850 million purchase of Metropolitan Health Networks, adding about 35 Florida primary care centers serving mainly Humana members and starting its senior primary care strategy. Medicare Advantage became the core business: the board approved a $2 billion buyback in 2014, and a whistleblower later alleged Humana kept two sets of Part D books from 2011 to 2017. CMS fined Humana $3.1 million in December 2015, the largest penalty on its list of 129 organizations, and Aetna agreed in July 2015 to buy Humana for $37 billion.
After a federal court blocked the Aetna deal, Humana ended the merger on February 14, 2017 and the same day said it would leave the ACA exchanges for 2018. It cut about 2,700 jobs in late 2017 and 800 more in 2019 despite strong results, and in 2018 took a 40% stake in Kindred at Home and joined the Curo hospice acquisition. Member-facing quality stayed high (92% of MA members were in 4-star-plus contracts for 2020), while OIG's April 2021 audit found nearly $200 million in risk-adjustment overcharges.
Humana completed its $5.7 billion acquisition of Kindred at Home and in 2022 launched CenterWell, uniting primary care, home health and pharmacy. A $1 billion value creation program drove layoffs including the SeniorBridge closures, Humana exited commercial employer insurance in 2023, and CMS fined it for overcharging enrollees. The period ended with a class action over the nH Predict algorithm, a $90 million Part D settlement in August 2024 and Jim Rechtin taking over as CEO in July 2024.
The share of Humana MA members in 4-star-plus plans fell from 94% under the 2024 Star Ratings to 25% under the 2025 ratings (20% under the 2026 ratings), leaving a net Stars headwind of about $3.5 billion for 2026 and making margin recovery the company's overriding goal. Humana lost two lawsuits against CMS over the ratings but won vacatur of CMS's RADV audit rule, while DOJ sued it over broker kickbacks and OIG and Senate investigators documented high post-acute denial rates. Plan and county exits affected about 560,000 members in 2025 and 194 counties for 2026, yet Humana kept richer benefits than rivals and gained 1.3 million members, then announced exits affecting about 600,000 members for 2027.
Alternatives
An integrated insurer-provider model: because Kaiser employs its own doctors and runs its own hospitals, it relies far less on prior authorization — KFF found Kaiser Medicare Advantage plans had just 0.6 prior authorization requests per enrollee in 2024, versus 2.2 for Humana — and its network is its own medical group rather than a directory of outside providers. The catch: Kaiser is only available in 8 states and D.C., and you must use Kaiser's own network exclusively. If you live in a Kaiser service area and have Medicare Advantage or employer plan choice, it's the clearest structural alternative.
For Humana Medicare Advantage enrollees: switching back to traditional fee-for-service Medicare paired with a Medigap supplemental policy largely avoids prior authorization, which traditional Medicare requires only for a limited set of services — sidestepping the kind of post-acute denials a Senate investigation found Humana issued at more than 16 times its overall denial rate. You can see any Medicare-accepting provider nationwide, with no network directory to rely on. Moderate switch — requires comparing Medigap plan options and timing the move to an enrollment window. Generally costs more in premiums but avoids Humana's benefit cuts and plan exits.
Dimensional Breakdown
Summaries below were written by AI agents based on the cited evidence. They are editorial interpretations, not independent research findings.
Dimension History
Timeline (58 events)
Humana Spins Off Hospital Division as Galen Health Care
After growing into a major hospital chain, Humana decided in 1993 to stake its future on managed care and in March spun off its hospital division, including 76 Humana hospitals, as Galen Health Care. Within six months Galen merged with Columbia Hospital Corp. (later Columbia/HCA) in a stock swap valued at $3.2 billion. The spinoff marked Humana's transformation from a hospital company into a health insurer.
Chipps Lawsuit Exposes Humana Denial Bonus Scheme
After a four-week trial in Palm Beach County, a Florida jury awarded the Chipps family about $1.03 million in compensatory and $78.5 million in punitive damages against Humana for terminating physical and occupational therapy for a young child with cerebral palsy. According to the family's law firm, the case uncovered that Humana paid bonuses to physicians and nurses based on the number of medical claims they denied each month. Florida's Fourth District Court of Appeal reversed the award in December 2001.
Humana Launches Medicare Part D Prescription Drug Plans
Humana began offering Medicare Part D prescription drug coverage on January 1, 2006, in 46 states and D.C., both as stand-alone plans and inside its Medicare Advantage HMO, PPO and private fee-for-service plans. Humana was not new to Medicare: by 2005 it already offered Medicare Advantage HMO and PPO plans in more than 40 markets and PFFS plans in more than 30 states. The Part D launch deepened its dependence on government-funded senior coverage.
Humana Among Seven Insurers to Suspend PFFS Marketing After CMS Concerns
CMS announced that Humana and six other health plan sponsors signed an agreement to voluntarily suspend marketing of Private Fee-For-Service Medicare Advantage plans in response to concerns about deceptive marketing practices targeting seniors. The suspension for each plan lasted until CMS certified that it met new conditions, including broker testing, beneficiary confirmation calls and disclaimer requirements; CMS cleared Humana to resume in September 2007.
Humana Acquires Concentra for $790 Million
Humana completed its acquisition of Concentra Inc. for approximately $790 million in cash, adding occupational medicine, urgent care and physical therapy services delivered from more than 300 medical centers in 42 states. The deal was an early step toward vertical integration into healthcare delivery, though Concentra focused on occupational health rather than senior care. Humana sold Concentra in 2015 to Select Medical and Welsh Carson for about $1.06 billion.
Humana Buys Metropolitan Health Networks for $850 Million
Humana completed its acquisition of Metropolitan Health Networks, a Boca Raton, Florida medical services organization, in a deal valued at about $850 million. Metropolitan coordinated care for about 87,500 Medicare Advantage, Medicaid and other beneficiaries through about 35 primary care centers and affiliated physicians serving mainly Humana members. The deal began Humana's strategy of owning the senior primary care practices its members use.
Humana Approves $2 Billion Share Buyback Replacing Existing $1 Billion Program
Humana's board replaced a $1 billion share repurchase authorization, of which $816 million remained unused, with a new $2 billion authorization expiring December 31, 2016, and said it intended to repurchase $1 billion of shares by mid-2015. The buybacks continued alongside rising executive compensation during a period of rapid Medicare Advantage enrollment growth.
Medicare Advantage Industry Accumulates $70 Billion in Improper Payments
The Center for Public Integrity's reporting found that federal officials made nearly $70 billion in improper payments to Medicare Advantage plans from 2008 through 2013, mostly inflated fees from overstating patients' health risks. The article noted a whistleblower suit alleging that a Humana-affiliated Miami clinic diagnosed an abnormally high number of patients with conditions that boosted Medicare payments, which Humana denied.
Whistleblower Alleges Humana Kept Two Sets of Part D Books (2011-2017)
A False Claims Act suit filed in 2016 by former Humana actuary Steven Scott alleged that from 2011 through 2017 Humana submitted fraudulent Medicare Part D bids to CMS, keeping one set of actuarial books for its government bids and a separate internal set with its actual anticipated costs, so that the government and beneficiaries unknowingly covered more than their share. Humana denied the allegations; the case settled in 2024.
Aetna Announces $37 Billion Acquisition of Humana
Aetna announced it would acquire Humana for approximately $37 billion in cash and stock, which would have created the nation's largest health insurer by Medicare Advantage enrollment. The merger would have combined two of the five largest U.S. health insurers, concentrating significant Medicare Advantage market power. The DOJ subsequently challenged the deal on antitrust grounds.
CMS Levies $3.1 Million Penalty on Humana for Part C and D Failures
CMS imposed a $3.1 million civil money penalty on Humana after a 2015 program audit found systemic failures in Part D formulary and benefit administration and in Part C and D coverage determinations, appeals and grievances, which left enrollees facing inappropriate delays or denials of covered benefits or higher out-of-pocket costs. It was the largest penalty on a list of 129 organizations CMS released in early 2016.
Federal Judge Blocks Aetna-Humana Merger on Antitrust Grounds
U.S. District Judge John D. Bates blocked Aetna's $37 billion acquisition of Humana, ruling it would substantially reduce competition for Medicare Advantage plans and individual exchange insurance. The court also found that Aetna had strategically withdrawn from insurance exchanges to pressure the DOJ into approving the merger. Aetna paid Humana a $1 billion breakup fee, and Humana remained independent.
Humana Ends Aetna Merger and Exits ACA Exchanges
On the same day Humana and Aetna ended their $37 billion merger after a court blocked it, Humana said it would not offer ACA exchange plans for 2018, citing an unbalanced risk pool. It had already cut its individual-market footprint by 1,195 counties in 2016, and the exit was expected to leave 16 Tennessee counties with no exchange insurer. Humana said it would return cash to shareholders and pursue acquisitions such as primary care clinics.
Humana Early Retirement Buyouts and 1,300 Layoffs Cut 2,700 Jobs
Humana confirmed it would lay off 1,300 employees as part of a workforce reduction initiative that, together with a voluntary early retirement program, was expected to affect about 2,700 employees, or 5.7% of its workforce. CEO Bruce Broussard said the goal was to improve productivity and free up funds to reinvest, as Humana adjusted to operating independently after the failed Aetna merger.
Humana Acquires 40% Stake in Kindred at Home for $800 Million
Humana agreed to acquire a 40% minority interest in Kindred Healthcare's homecare business, the nation's largest home health operator, for approximately $800 million through a joint venture with private equity firms TPG Capital and Welsh, Carson, Anderson & Stowe. The stake came with a path to buy the remainder and laid the groundwork for Humana's vertical integration into home health services and self-referral dynamics between its insurance and provider operations.
Humana Consortium Completes Curo Hospice Acquisition
Humana, with private equity firms TPG and Welsh, Carson, Anderson & Stowe, completed the purchase of Curo Health Services, a hospice operator with 245 locations in 22 states, planning to combine it with Kindred at Home's hospice business to create the country's largest hospice operator. It followed the consortium's July 2 closing of the Kindred Healthcare deal, which gave Humana a 40% stake in Kindred at Home.
92% of Humana MA Members in 4-Star-Plus Contracts for 2020
Humana said 3.7 million, or about 92%, of its Medicare Advantage members were in contracts rated 4 stars or higher for 2020, with 18 contracts at 4 stars or above and a 5-star rating for its CarePlus plan in Florida. The results reflected Humana's standing as one of the program's quality leaders before its 2024 ratings collapse.
Humana Cuts 800+ Jobs Despite Strong Financials
Humana announced plans to cut more than 800 employees by the end of 2019, even as analysts described the company as financially strong and its Medicare membership was growing. An analyst noted Humana had cut 2,700 employees about two years earlier, reflecting a pattern of continuous restructuring.
OIG Audit Finds Humana Overcharged Medicare by Nearly $200 Million
An HHS Office of Inspector General audit found that Humana's Florida health plan improperly collected approximately $197.7 million in 2015 by overstating how sick some patients were through inaccurate diagnosis codes. The overpayment came from a plan that received $5.6 billion in Medicare payments for approximately 485,000 members. OIG recommended full repayment and improved compliance controls, though Humana contested the methodology.
Humana Completes $5.7 Billion Acquisition of Kindred at Home
Humana completed the acquisition of the remaining 60% of Kindred at Home for $5.7 billion in cash and debt, gaining full ownership of the nation's largest home health and hospice provider. The acquisition gave Humana direct control over home health delivery for its Medicare Advantage members, deepening vertical integration and creating self-referral pathways between Humana insurance plans and Humana-owned home health agencies.
Humana Launches $1 Billion Value Creation Cost-Cutting Initiative
Humana announced a $1 billion value creation initiative, about three-quarters of it from savings including workforce cuts, trimming vendor spending, automating tasks and selling parts of its real estate portfolio. Executives said the proceeds would go primarily to growing Medicare Advantage membership and the pharmacy, provider and home-based care businesses. Humana later closed its SeniorBridge home care business as part of the initiative.
Humana Launches CenterWell Brand Unifying Healthcare Services
Humana rebranded its Kindred at Home home health business as CenterWell Home Health in three phases during 2022, finishing in September with more than 350 locations in 38 states. The move brought home health under the same CenterWell brand as Humana's senior primary care and pharmacy businesses, creating a single vertically integrated healthcare services platform under the Humana umbrella.
OIG Finds 18% of MA Prior Authorization Denials Were Improper
An HHS OIG report found that 13% of prior authorization denials by Medicare Advantage organizations were for requests that met Medicare coverage rules, and 18% of payment denials were for claims that met Medicare coverage and billing rules, delaying or preventing medically necessary care. Humana was among the 15 largest MA organizations whose denials were sampled. Imaging, post-acute stays and injections were prominent among the improper denials.
Senate Report Finds Deceptive Marketing Flourishes in Medicare Advantage
A Senate Finance Committee majority staff report, launched after CMS said Medicare Advantage marketing complaints more than doubled from 2020 to 2021, found evidence that beneficiaries were inundated with aggressive marketing tactics and false and misleading information, and examined the commission incentives that drive brokers and agents. The report addressed industry-wide practices and did not single out Humana.
CMS Fines Humana for Overcharging Enrollees
CMS imposed a $131,660 civil money penalty on Humana across 31 Medicare contracts after a financial audit of 2019 data found it failed to meet Part D drug cost and out-of-pocket accumulator rules, retroactive claims adjustment rules and Part C cost-sharing rules. CMS said Humana overcharged enrollees for Part D medications and Part C services.
Humana Exits Commercial Employer Insurance to Focus on Medicare
Humana announced it would exit the employer group commercial medical business, including fully insured and self-funded plans, winding it down over 18 to 24 months because the segment no longer fit its long-term strategy. The decision concentrated Humana's business on government-funded programs, deepening its dependence on Medicare payment structures and star rating bonuses.
SeniorBridge Closures Complete with 1,162 Workers Laid Off
Humana completed the closure of its 23 SeniorBridge home care facilities, laying off at least 1,162 employees in two states, including 149 caregivers at the Jupiter, Florida location. The closures followed Humana's $1 billion value creation initiative, which prioritized Medicare Advantage investment over maintaining the home care service line.
Class Action Alleges Humana Used AI Algorithm to Deny Care
Medicare Advantage beneficiaries filed a class-action lawsuit in federal court in Western Kentucky alleging Humana illegally used the nH Predict algorithm, developed by UnitedHealth subsidiary NaviHealth, to prematurely cut off payment for rehabilitation care. The suit argued Humana's reliance on the algorithm was part of a fraudulent scheme to reap a windfall by systematically denying claims.
CenterWell Plans to Route Nearly All Primary Care Patients to Owned Home Health
Humana said it expected to serve nearly all of its CenterWell Primary Care patients who use home health through its own CenterWell Home Health and onehome agencies, where coverage overlaps, by the end of 2024, driving a 25% increase in value-based home health admissions. This self-referral strategy exemplifies the closed-ecosystem approach where Humana captures revenue at both the insurance and provider stages, potentially limiting members' choice of independent home health providers.
Humana Settles Part D Fraud Whistleblower Case for $90 Million
Humana agreed to pay $90 million to settle a whistleblower lawsuit alleging it submitted fraudulent bids to CMS for Medicare Part D contracts from 2011 to 2017. Former Humana actuary Steven Scott alleged the company kept two sets of books, and that it pocketed the difference, which he put at hundreds of millions of dollars. Humana settled on the eve of trial without admitting wrongdoing and denied the allegations.
Star Ratings Collapse: 94% to 25% in 4-Star Plans
Humana disclosed that only about 25% of its Medicare Advantage members were in plans rated 4 stars or above for 2025, down from 94%, after a contract covering about 45% of its MA members fell from 4.5 to 3.5 stars. A Cantor Fitzgerald analyst estimated the drop could affect nearly $3 billion of 2026 revenue. Shares fell more than 20% in morning trading before partly recovering.
Senate Investigation Finds Humana Post-Acute Denial Rate 16x Overall
A Senate investigation documented that Humana's prior authorization denial rate for post-acute care services was more than 16 times higher than its overall denial rate, with long-term acute care hospital denial rates increasing 54% between 2020 and 2022. The report found that Humana had conducted training sessions that led to escalated denial rates for expensive post-acute services, indicating targeted algorithmic restriction of costly care categories.
Humana Sues CMS Over Star Ratings, Loses Lawsuit
Humana sued HHS in a Texas federal court, alleging its 2025 star ratings were arbitrary and capricious and asking the court to force a recalculation. CMS denied Humana's parallel administrative appeal in April 2025, and in July 2025 the judge dismissed the suit because Humana had filed it before exhausting administrative remedies. The litigation strategy of suing the regulator rather than addressing underlying quality issues reflected Humana's confrontational regulatory posture.
Minnesota AG Presses Humana Over Out-of-Network Providers Listed as In-Network
After the Minnesota Star Tribune reported that Humana listed Essentia Health, Avera Health, North Memorial Health and Sanford Health as in-network for 2025 Medicare Advantage plans despite those systems announcing they would be out-of-network, Attorney General Keith Ellison sent Humana a letter asking it to correct the alleged misinformation and explain how widely it had been shared and what it would do for affected consumers.
CMS Fines Humana Over Low-Income Subsidy Claims
CMS imposed a $99,064 civil money penalty on Humana after a financial audit found that in 2021 it failed to reprocess prescription drug claims to reflect enrollees' low-income subsidy levels within 45 days of receiving complete information.
CenterWell Pharmacy Fulfills Novo Nordisk's $499 Direct-to-Patient Wegovy
Novo Nordisk launched NovoCare Pharmacy, a direct-to-patient option selling all doses of Wegovy to cash-paying patients for $499 per month, with home shipments fulfilled by Humana's CenterWell Pharmacy. The arrangement extended CenterWell's pharmacy business into cash-pay GLP-1 sales outside Humana's own insurance plans.
Court Certifies Robocall Class Action Against Humana
A federal court in Kentucky certified a Telephone Consumer Protection Act class in Elliot v. Humana covering people who received prerecorded Humana calls on cell numbers not assigned to Humana customers. The plaintiff said Humana's own data showed 23,682 people received at least one prerecorded call after being flagged as a wrong number.
CenterWell Segment Hits $5.1 Billion Quarterly Revenue with 34.6% Profit Growth
Humana's CenterWell segment reported $5.1 billion in Q1 2025 revenue with adjusted operating income of $451 million, up 34.6% year-over-year, and Humana kept CenterWell's 2025 revenue guidance at $20.5-21.5 billion. The vertical integration model increasingly monetized member health needs across insurance, primary care, home health, and pharmacy channels simultaneously.
DOJ Sues Humana Over Medicare Advantage Broker Kickbacks
The Department of Justice filed a False Claims Act complaint alleging Humana, along with Aetna and Elevance, paid hundreds of millions of dollars in illegal kickbacks to brokers eHealth, GoHealth, and SelectQuote from 2016 through at least 2021 in exchange for steering Medicare beneficiaries into their plans. The DOJ further alleged Humana conspired with brokers to discriminate against disabled Medicare beneficiaries perceived as less profitable by threatening to withhold payments.
CenterWell Bids $50 Million for Bankrupt The Villages Health
Humana's CenterWell agreed to a $50 million stalking-horse deal for The Villages Health, a Central Florida provider with eight primary care and two specialty centers that filed for bankruptcy after finding it owed Medicare hundreds of millions of dollars. The purchase extended Humana's strategy of owning providers so it can pay itself for care and keep more of members' spending in-house.
Humana Offers Early Retirement Buyouts to Employees 50 and Older
Humana offered voluntary early retirement buyouts to employees age 50 or older with at least three years of service, excluding business-critical areas, paying two weeks per year of service plus a job-level amount, capped at 52 weeks. Humana had more than 64,000 employees at the end of 2024; how many received the offer was not disclosed.
Humana's 2025 Plan and County Exits Affect About 560,000 Members
Humana's second-quarter 2025 prepared remarks said its decision to exit certain unprofitable Medicare Advantage plans and counties for 2025 affected about 560,000 members, of whom it had recaptured about 43% into other Humana MA plans. It now expected a full-year 2025 decline of up to 500,000 individual MA members, better than the roughly 550,000 it had forecast.
Court Lets nH Predict Denial Claims Against Humana Proceed
A federal judge in Kentucky granted in part and denied in part Humana's motion to dismiss the class action alleging it used the nH Predict model to cut off post-acute care for Medicare Advantage members. Claims for breach of contract, breach of the implied covenant of good faith, unjust enrichment and common-law fraud may proceed, while state unfair-practice and bad-faith claims were dismissed. Plaintiffs allege employees who deviated from the model's output were disciplined.
Humana Lawsuit Gets CMS Risk Adjustment Audit Rule Vacated
Judge Reed O'Connor of the Northern District of Texas granted Humana summary judgment and vacated CMS's 2023 RADV rule, which would have let the government extrapolate audit findings and recoup billions of dollars in Medicare Advantage overpayments over the next decade. The court found the rule procedurally invalid. The government appealed to the Fifth Circuit in November 2025.
Court Orders Humana to Pay $32 Million in Whistleblower's Legal Fees
Chief U.S. District Judge Greg Stivers ruled that Humana must pay the legal fees and costs of whistleblower Steven Scott's lawyers in the Part D bid-fraud case Humana settled for $90 million in 2024, while rejecting a larger $41 million request. According to court filings, Scott's share of the recovery was about $26.1 million, or 29% of the government's settlement, a larger share because the Justice Department had declined to intervene.
Humana Exits Three States and 194 Counties for 2026
Humana offered Medicare Advantage plans in three fewer states and 194 fewer counties for 2026, part of a broader retrenchment by UnitedHealthcare, Humana and Aetna to recover margins that analysts said would push hundreds of thousands of seniors to shop for new plans. The cuts followed the star ratings collapse. Industry-wide, average general-enrollment MA premiums rose almost 22% for 2026 (Morgan Stanley).
Humana Appeals Star Ratings Loss to Fifth Circuit
After a Texas federal court rejected its second lawsuit over its 2025 star ratings, Humana appealed to the Fifth Circuit. The ratings, lowered partly over three unsuccessful call-center test calls, were expected to cut its 2026 revenue by $1 billion or more.
OIG Audit Finds Noncompliant Diagnosis Codes at Humana Louisiana
An HHS OIG audit of Humana Health Benefit of Louisiana found that most selected diagnosis codes submitted to CMS for risk adjustment did not comply with federal requirements: for 218 of 240 sampled enrollee-years, medical records did not support the codes. OIG estimated at least $10.5 million in overpayments for 2017-2018 and recommended a $5.5 million refund; Humana disagreed. The audit was part of a broader OIG series on MA risk adjustment.
Humana Speeds Prior Authorization Decisions and Launches Gold Card
Humana said it had removed prior authorization for more than 340 codes across 2024 and 2025, about one-third of prior authorizations for outpatient diagnostic services such as colonoscopies and select CT and MRI scans. From January 1, 2026 it committed to decide at least 95% of complete electronic requests within one business day, and it launched a national gold card program waiving prior authorization for providers with strong records.
Humana Guides to Lower 2026 Earnings on Star Ratings Headwind
Humana's Q4 2025 earnings release guided 2026 adjusted EPS to 'at least $9.00', a year-over-year decline it attributed to the Star Ratings headwind for bonus year 2026, net of mitigation, even as it expected individual Medicare Advantage membership to grow about 25%. On the earnings call, CFO Celeste Mellet put the net Stars headwind for 2026, across individual and group MA, at approximately $3.5 billion, larger than previously discussed because of membership growth. She said 45% of members were in four-star-plus plans for 2026, the bonus year set by the 2025 Star Ratings, with 70% of new sales in such plans; the 20% Humana disclosed in October 2025 was under the 2026 Star Ratings, which set 2027 payments, and was based on its membership at that time.
CenterWell Acquires MaxHealth's Florida Clinics
Humana's CenterWell bought MaxHealth from private equity firm Arsenal Capital Partners, adding 54 primary care clinics, four specialty and ancillary locations and 24 affiliated clinics in West and South Florida serving more than 120,000 patients. CenterWell's primary care arm already ran 350 locations in 15 states, and the segment's revenue reached $22.5 billion in 2025.
Humana Notifies Members of Breach Exposing SSNs and Claims Data
Humana notified an undisclosed number of people that attackers accessed its internal systems in August 2025 through a vendor's software vulnerability, exposing names, Social Security numbers, member IDs and medical claims information; its CenterWell subsidiary also sent notices. The Clop group claimed the attack, and class actions were filed against Humana and CenterWell.
Judge Denies Insurers' Bid to Dismiss DOJ Broker Kickback Case
A federal judge in Massachusetts denied the motion by Humana, Aetna and Elevance to dismiss the Justice Department's False Claims Act case alleging they paid brokers hundreds of millions of dollars from 2016 to 2021 to steer beneficiaries away from competitors' plans, and that Humana and Aetna tied payments to limiting enrollment of people with disabilities. Only an unjust enrichment claim was dismissed.
Humana Adds 1.3 Million MA Members, Puts Margin Recovery First
Humana ended the first quarter of 2026 with 7.1 million Medicare Advantage members, 1.3 million more than at the end of 2025, after keeping richer benefits while rivals cut back. CEO Jim Rechtin repeatedly told investors that returning to a 3% MA margin in 2028 is the company's top priority, ahead of member retention, with MA margins expected slightly below breakeven in 2026.
OIG Finds Humana Among Top Post-Acute Care Deniers
HHS OIG published two reports on June 2024 prior authorization data finding that UnitedHealth, Humana and CVS denied post-acute admission requests at higher rates than most peers, each rejecting more than 70% of long-term care hospital requests and more than 50% of inpatient rehabilitation requests. Across insurers, 95% of appealed skilled nursing facility denials were overturned, which OIG said indicated some enrollees were initially denied medically necessary care.
Major Health Systems Leave Humana's MA Network
Moffitt Cancer Center went out of network with Humana Medicare Advantage on July 1, 2026, following UNC Health and Centra Health in January, while St. Luke's, Kettering Health and Montrose Regional Health also stopped contracting with Humana MA and Mayo Clinic went out of network with most Humana MA plans. Humana notified Ohio State's Wexner Medical Center it was terminating that contract effective October 1.
Senate Investigators Press Humana on Post-Acute Denials
The Senate Permanent Subcommittee on Investigations wrote to CEO Jim Rechtin that new OIG data showed Humana denied 72% of inpatient rehabilitation admission requests, versus an average of 41% at 16 smaller insurers, and 13.5% of skilled nursing requests, almost all of which were overturned when appealed. The senators said the data called into question Humana's claims to be reining in prior authorization and requested records back to January 2023.
Humana to Exit MA Plans Covering About 600,000 Members for 2027
Humana said it will shut Medicare Advantage plans with lower capital returns for 2027, affecting roughly 600,000 seniors, about 8% of its 7.2 million MA members, the second straight year of exits. The CFO said the goal is to stay on track for a sustainable margin of at least 3% in 2028, and Humana expects to recapture about 40% of affected members in other plans.
Evidence (54 citations)
D1: User Value Erosion
D2: Business Customer Exploitation
D3: Shareholder Extraction
D4: Lock-in & Switching Costs
D5: Twiddling & Algorithmic Opacity
D6: Dark Patterns
D7: Advertising & Monetization Pressure
D8: Competitive Conduct
D9: Labor & Governance
D10: Regulatory & Legal Posture
Scoring Log (8 entries)
[Second regrade this cycle] 57->57, no dimension moved. Restored facts weighed: D1 - FY2025 plan/county exits affecting ~560,000 members (decline up to 500,000, 43% recaptured) add a third straight year of exits but sit in the same 6-7 band already scored 6 on 2026/2027 exits; the ~$3.5B net 2026 Stars headwind is lost bonus revenue to Humana, not a further member-facing decline, and the reconciled 45% of 2026 members in 4+ star plans (bonus year 2026) slightly mitigates the 20% figure, so D1 stays 6. D3 - $3.5B headwind explains near-breakeven 2026 MA margins and the margin-first exits already scored; no new buyback, pay or layoff facts, stays 5. D10 - Sept 2025 order to pay >$32M of whistleblower fees ($26.1M/29% relator share) is a coda to the $90M Part D settlement already counted; stays 7. Reconciled 20% vs 45%: 20% = preliminary 2026 Star Ratings on Oct 2025 membership (payment year 2027, per Humana 8-K 2025-10-02); 45% = share of 2026 members in 4+ star plans for bonus year 2026 (2025 ratings), per Q4 2025 call. Updated timeline #48, evidence #0 title, D1/D3/D10 summaries and narratives, current-era summary; added 2025-exit timeline event and 8-K evidence. Eras: all 5 kept (dates, labels, scores unchanged); current-era summary revised. Trajectory stable.
Checked 83 items + prose. 25 verified, 38 corrected (14 date-only), 16 re-sourced, 4 removed (2 duplicates, 2 junk sources). Invented/unsupported specifics: $3.5B star headwind (AI MarketMinute page), $599-$699/vial GLP-1 price, '30,000 employees' offered buyouts, '500,000 members' displaced (broker page only). Fixed swapped OIG 13%/18% figures, Louisiana audit numbers, 2006 'MA entry' (Part D launch), industry-wide 22% premium rise attributed to Humana, Chipps reversal, star-lawsuit sequence.
59->57. D1 7->6 (correction: fact audit removed the unsupported $3.5B headwind and '500,000 displaced' claims; with 2026 benefit stability, 1.3M new members, PA cuts and a below-average overall denial rate, the record fits 6 despite 2027 exits and OIG post-acute findings). D4 6->5 (recalibration: MA switching is annual and the average beneficiary has 8 parent organizations; CenterWell ties are real but partial). Others unchanged. Eras: era 0 kept; 'MA Growth & Consolidation' re-dated 2012-01-01->2012-12-21 (Metropolitan Health acquisition); 'Post-Merger Independence' re-dated 2017-06-01->2017-02-14 (merger ended + ACA exit); 'CenterWell Integration' re-dated 2021-08-01->2021-08-17; 'Star Ratings Collapse' (2024-10-01) and assessment-dated 'Benefit Retrenchment' (2026-02-16) merged at 2024-10-02 and relabeled 'Stars Collapse & Retrenchment' (same forces, same scores). Trajectory worsening->stable (2027 exits and OIG findings offset by 2026 benefit stability, PA reductions). Since Sep 2025: RADV rule vacated on Humana's suit, star-suit appeal to 5th Cir, MaxHealth and Villages Health buys, breach notices, DOJ kickback MTD denied, 1.3M member surge with margin-first strategy, OIG/Senate post-acute denial findings, health systems leaving network, 2027 exits of ~600k members.
Checked 10 removed/trimmed claims: 1 restored, 5 partly restored, 4 confirmed removed, 0 already present. Restored: whistleblower $26.1M/29% share (new timeline event, Insurance Business 2025-09-25 fee ruling). Partly restored: Galen-Columbia $3.2B stock swap (Encyclopedia.com; added d8 evidence); $3.5B net 2026 Stars headwind (Motley Fool Q4 2025 call transcript; timeline #46 + d1 evidence, 'shares plunged' left out); MarketMinute evidence re-sourced to that transcript; CenterWell-Novo partnership (new timeline event, Novo release 2025-03-05, $499/month not $599-699); 500,000-member decline re-dated to FY2025 (Humana Q2 2025 remarks 8-K, d1 evidence). Confirmed removed: 77 hospitals/'nation's largest'; '27% over four years' (only search snippets, WDRB article unreadable, no archive); Senate/CMS inquiry naming Humana; MN AG 'one of the first'; 30,000 buyout offers and outsourcing.
Triaged 2026-06-30 (Wave A); no rescore warranted (no material change / changes sub-threshold / flag refuted on verification).